MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 375 filers reported holding MEDIVATION INC in Q2 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $22,640,000 | -18.7% | 198,252 | -8.2% | 0.02% | -20.8% |
| Q1 2015 | $27,864,000 | +21.7% | 215,883 | -6.1% | 0.02% | +4.3% |
| Q4 2014 | $22,904,000 | -2.5% | 229,934 | -3.3% | 0.02% | -11.5% |
| Q3 2014 | $23,501,000 | +33.2% | 237,700 | +3.9% | 0.03% | +23.8% |
| Q2 2014 | $17,642,000 | +13.9% | 228,876 | -4.9% | 0.02% | +5.0% |
| Q1 2014 | $15,489,000 | +5.4% | 240,618 | +4.5% | 0.02% | 0.0% |
| Q4 2013 | $14,693,000 | +36.2% | 230,232 | +27.9% | 0.02% | +25.0% |
| Q3 2013 | $10,790,000 | +157.4% | 180,012 | +111.2% | 0.02% | +166.7% |
| Q2 2013 | $4,192,000 | – | 85,213 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
| Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
| BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
| PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
| Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
| Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
| Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
| Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
| Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |